Molecular Mechanisms in the Carcinogenesis of Oral Squamous Cell Carcinoma: A Literature Review
Top Cited Papers
Open Access
- 25 April 2025
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 15 (5) , 621
Abstract
The tumor microenvironment (TME) plays a crucial role in the development, progression, and metastasis of oral squamous cell carcinoma (OSCC). The TME comprises various cellular and acellular components, including immune cells, stromal cells, cytokines, extracellular matrix, and the oral microbiome, all of which dynamically interact with tumor cells to influence their behavior. Immunosuppression is a key feature of the OSCC TME, with regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), and tumor-associated macrophages (TAMs) contributing to an environment that allows tumor cells to evade immune surveillance and supports angiogenesis. The oral microbiome also plays a pivotal role in OSCC pathogenesis, as dysbiosis, or imbalances in the microbiota, can lead to chronic inflammation, which promotes carcinogenesis through the production of pro-inflammatory cytokines and reactive oxygen species (ROS). Pathogens like Porphyromonas gingivalis and Fusobacterium nucleatum have, hence, been implicated in OSCC-driven tumor progression, as they induce inflammation, activate oncogenic pathways, and modulate immune responses. In this review, we discuss how the interplay between immunosuppression and microbiome-driven inflammation creates a tumor-promoting environment in OSCC, leading to treatment resistance and poor patient outcomes, and explore the potential therapeutic implication of a better understanding of OSCC etiology and molecular changes.Keywords
Funding Information
- CAPES—Foundation Coordination for the Improvement of Higher Education Personnel—Cabral, LGC (88887.630761/2021-00)
This publication has 221 references indexed in Scilit:
- The role of non‐coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potentialCancer Communications, 2021
- Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunitiesInternational Journal of Cancer, 2020
- MiR‐34a inhibits the proliferation, migration, and invasion of oral squamous cell carcinoma by directly targeting SATB2Journal of Cellular Physiology, 2019
- LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR‐548d‐3p to modulate JAK–STAT pathway in oral squamous cell carcinomaIUBMB Life, 2019
- PTENp1, a natural sponge of miR‐21, mediates PTEN expression to inhibit the proliferation of oral squamous cell carcinomaMolecular Carcinogenesis, 2016
- MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinomaHead & Neck, 2014
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Histone modification patterns correlate with patient outcome in oral squamous cell carcinomaCancer, 2013
- TP53 and head and neck neoplasmsHuman Mutation, 2003
- Genomic instability in head and neck cancer patientsHead & Neck, 2001